Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cyanotech Corporation
Cyanotech Focuses Natural Astaxanthin Production on BioAstin(R) for Human Market, Discontinues Production of NatuRose(R) for Animal Feed Market in Strategic Move
April 12th, 2008
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in producing high-value nutrition and health products from microalgae, announced that it will discontinue marketing of its NatuRose(R) product for the animal feed market in order to focus production and marketing of natural astaxanthin exclusively on the higher value human market. "Cyanotech's marketing efforts and investment directed toward the human astaxanthin market in recent periods have yielded excellent results," said Gerald R. Cysewski, Ph.D., Cyanotech's Chairman, President and Chief Executive Officer. "Our sales of BioAstin, the industry-leading brand in the human astaxanthin market, recorded...
Source: Law & Health Weekly (2008-04-12)
|
